Picture of Replicel Life Sciences logo

RP — Replicel Life Sciences News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Brief: Replicel life science says U.S. patent issued to co

April 25 (Reuters) - Replicel Life Sciences Inc  RP.V  
    * Replicel Life Sciences Inc - United States patent issued 
to Replicel for its novel dermal injection technologies 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nCNWYcpVPa 
Further company coverage:  RP.V  
 
 ((bangalore.newsroom@thomsonreuters.com;))

Recent news on Replicel Life Sciences

See all news